Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison
迪努妥昔单抗β与纳西他单抗治疗复发/难治性神经母细胞瘤患者的疗效比较：系统评价和匹配调整间接比较，这些患者病情稳定、轻微缓解或部分缓解，且伴有骨或骨髓转移。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172723
Lode, Holger N; Holko, Przemysław; Wieczorek, Aleksandra; Siebert, Nikolai; Valteau-Couanet, Dominique; Garaventa, Alberto; Cañete, Adela; Anderson, John; Yaniv, Isaac; Ash, Shifra; Gray, Juliet; Luksch, Roberto; Manzitti, Carla; Troschke-Meurer, Sascha; Ebeling, Torsten; Kawalec, Paweł; Śladowska, Katarzyna; Ladenstein, Ruth L
